Shareholders Equity ratio Analysis of Onconova Therapeutics Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Shareholders Equity of ONTX
Dec-23
47.05
Indecisive Shareholders Equity
Dec-22
71.90
Very Good Shareholders Equity
Growth
-34.57
%
Shareholders Equity Analysis of Onconova Therapeutics Inc
Shareholders Equity Ratio of ONTX drastically fell by -34.57 % this year.
Shareholders Equity Ratio with value of 83.13 was highest in Year Dec-21 in last Five Years.
Shareholders Equity Ratio with value of 31.21 was lowest in Year Dec-20 in last Five Years.
Latest Shareholders Equity Ratio with value of 47.05 is lower than Average Shareholders Equity of 56.44 in last five years.
Other Shareholders Equity Related Info of ONTX that may interest you.
Onconova Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
ONTX0.99531.0 0.470 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
Poor Stability Stock
FY - Historical Shareholders Equity of Onconova Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Shareholders Equity47.0571.9083.1331.2148.8930.06-234.81
Change-34.57 %-13.51 %166.35 %-36.16 %62.66 %112.80 %-1369.55 %
You are view first 7 Records. Log in to view all 13 in Premium view
FY Chart of Shareholders Equity of Onconova Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)